Indivior (LON:INDV) Stock Price Down 15.7% – Here’s Why

Indivior PLC (LON:INDV) shares traded down 15.7% during trading on Thursday . The company traded as low as GBX 548.71 ($6.95) and last traded at GBX 732 ($9.28). 1,888,371 shares changed hands during mid-day trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($11.00).

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.81) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Performance

The company has a market capitalization of £1.14 billion, a P/E ratio of -606.93, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The firm has a 50 day moving average price of GBX 924.76 and a two-hundred day moving average price of GBX 852.88. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.